Protocol No.: MK3475-630-07

Title
A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate Pembrolizumab Versus Placebo as Adjuvant Therapy Following Surgery and Radiation in Participants with High-risk Locally Advanced Cutaneous Squamous Cell Carcinoma
Principal Investigator
Najeeb, Sidra
Phase
III
Age Group
Adult
Applicable Disease Site
Melanoma and Other Skin Cancers
Participating Institution
Mary Babb Randolph Cancer Center
Contact
Abby Swiger, RN
Research Nurse
Phone: +1 304-293-1683

View on ClinicalTrials.gov